檢索結果 - Jacqueline Nicholas
- Showing 1 - 8 results of 8
-
1
-
2
-
3
-
4
Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US 由 Daniel Ontaneda, Jacqueline Nicholas, Matthew Carraro, Jia Zhou, Qiang Hou, Jaanai Babb, Katherine Riester, Jason P. Mendoza, Terrie Livingston, Mehul Jhaveri
出版 2018Artigo -
5
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years 由 Stephen L. Hauser, Anne H. Cross, Kevin Winthrop, Heinz Wiendl, Jacqueline Nicholas, Sven G. Meuth, Paul S. Giacomini, Francesco Saccà, Linda Mancione, Ronald Zielman, Morten Bagger, Ayan Das Gupta, Dieter A. Häring, Valentine Jehl, Bernd C. Kieseier, Ratnakar Pingili, Dee Stoneman, Wendy Su, Roman Willi, Ludwig Kappos
出版 2022Artigo -
6
Associations of<scp>sNfL</scp>with clinico‐radiological measures in a large<scp>MS</scp>population 由 Elias S. Sotirchos, Kathryn C. Fitzgerald, Carol M. Singh, Matthew D. Smith, Maria Reyes‐Mantilla, Carrie M. Hersh, Megan Hyland, Ryan Canissario, Sarah B. Simmons, Georgina Arrambide, Xavier Montalbán, Manuel Comabella, Robert T. Naismith, Min Qiao, Lauren Krupp, Jacqueline Nicholas, Katja Akgün, Tjalf Ziemssen, Richard A. Rudick, Elizabeth Fisher, Robert Bermel, Ellen M. Mowry, Peter A. Calabresi
出版 2022Artigo -
7
Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) 由 Ellen M. Mowry, Robert Bermel, James R. Williams, Tammie L.S. Benzinger, Carl de Moor, Elizabeth Fisher, Carrie M. Hersh, Megan Hyland, Izlem Izbudak, Stephen E. Jones, Bernd C. Kieseier, Hagen H. Kitzler, Lauren Krupp, Yvonne W. Lui, Xavier Montalbán, Robert T. Naismith, Jacqueline Nicholas, Fabio Pellegrini, Àlex Rovira, Maximilian Schulze, Björn Tackenberg, Mar Tintoré, Madalina E. Tivarus, Tjalf Ziemssen, Richard A. Rudick
出版 2020Artigo -
8
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study 由 Amit Bar‐Or, Heinz Wiendl, Xavier Montalbán, Enríque Alvarez, M. V. Davydovskaya, Silvia Delgado, Evgeniy Evdoshenko, Nataša Giedraitienė, Katrin Gross‐Paju, Sulev Haldre, Craig Herrman, Guillermo Izquierdo, Guntis Karelis, Fritz Leutmezer, Miroslav Mareš, José Meca-Lallana, Dalia Mickevičienė, Jacqueline Nicholas, Derrick Robertson, Д В Сазонов, Kenneth Sharlin, Bharathy Sundaram, N. А. Totolyan, Marta Vachová, Martin Vališ, Morten Bagger, Dieter A. Häring, Inga Ludwig, Roman Willi, Martin Zalesak, Wendy Su, Martin Merschhemke, Edward Fox
出版 2021Artigo
相關主題
Medicine
Internal medicine
Multiple sclerosis
Immunology
Fingolimod
Environmental health
Population
Teriflunomide
Adverse effect
Confidence interval
Dimethyl fumarate
Disease
Family medicine
Lymphoma
Meta-analysis
Ofatumumab
Rituximab
Tolerability
Atrophy
Bioequivalence
Cmax
Cohort
Computer science
Cumulative incidence
Discontinuation
Economic growth
Economics
Engineering
Expanded Disability Status Scale
Gastroenterology